First Trial Begins for Kakao’s Kim Beom-su Over Stock Manipulation Allegations in SM Entertainment Takeover

Reporter Kim Jisun / approved : 2024-09-12 06:53:01
  • -
  • +
  • 인쇄

(Photo= Yonhap news)

 

[Alpha Biz= Reporter Kim Jisun] During the first trial of Kim Beom-su, chairman of Kakao’s Management Innovation Committee, prosecutors emphasized his direct involvement in stock manipulation related to SM Entertainment's acquisition. On the other hand, Kim’s defense denied the charges, arguing that his actions were part of legitimate management activities and that there was no intent to manipulate the stock price.

The trial, held on the 11th at the Seoul Southern District Court, follows Kim’s indictment on charges of violating the Capital Markets Act. Prosecutors allege that Kim orchestrated stock manipulation in February 2022 to obstruct HYBE’s tender offer for SM Entertainment, aiming to hinder their acquisition process.

The prosecution argued that despite opposition from Kakao’s former CFO, Kim approved the acquisition strategy in a January 2022 meeting. They claim Kim instructed that SM’s stock price should not rise, stressing that Kakao’s involvement should remain hidden.

Prosecutors further allege that Kim ordered his team to devise strategies to block HYBE's tender offer without making Kakao's actions obvious, indicating potential behind-the-scenes manipulation. The defense continues to deny any wrongdoing, maintaining that the acquisition was handled within legal bounds.

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Bomb Threats Target Major Korean Companies Including Samsung Electronics2025.12.19
FSS Raises Consumer Alert to “Warning” Over Secondary Scams Linked to Coupang Data Breach2025.12.19
Final U.S. Defense Authorization Bill Omits Provisions Supporting South Korea-Japan Shipbuilding Cooperation2025.12.19
Controversy Surrounds KT’s Former Outside Director Cho Seung-ah Amid Dual Directorship Issue2025.12.19
Samsung Securities Lowers LG Energy Solution Target Price to KRW 480,000 Amid Contract Cancellations2025.12.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사